FR2416231B1 - - Google Patents

Info

Publication number
FR2416231B1
FR2416231B1 FR7902671A FR7902671A FR2416231B1 FR 2416231 B1 FR2416231 B1 FR 2416231B1 FR 7902671 A FR7902671 A FR 7902671A FR 7902671 A FR7902671 A FR 7902671A FR 2416231 B1 FR2416231 B1 FR 2416231B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7902671A
Other versions
FR2416231A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GCP Products UK Ltd
WR Grace and Co Conn
Original Assignee
WR Grace Ltd
WR Grace and Co Conn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/955,705 external-priority patent/US4228079A/en
Application filed by WR Grace Ltd, WR Grace and Co Conn filed Critical WR Grace Ltd
Publication of FR2416231A1 publication Critical patent/FR2416231A1/fr
Application granted granted Critical
Publication of FR2416231B1 publication Critical patent/FR2416231B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
FR7902671A 1978-02-01 1979-02-01 Derives dialkoxyles du monorden, leur preparation et leurs utilisations comme agents antitumeur Granted FR2416231A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87434878A 1978-02-01 1978-02-01
US05/955,705 US4228079A (en) 1978-10-30 1978-10-30 Dialkoxy monorden derivatives

Publications (2)

Publication Number Publication Date
FR2416231A1 FR2416231A1 (fr) 1979-08-31
FR2416231B1 true FR2416231B1 (fr) 1981-08-14

Family

ID=27128335

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7902671A Granted FR2416231A1 (fr) 1978-02-01 1979-02-01 Derives dialkoxyles du monorden, leur preparation et leurs utilisations comme agents antitumeur

Country Status (5)

Country Link
JP (1) JPS54112885A (fr)
DK (1) DK40279A (fr)
FR (1) FR2416231A1 (fr)
IT (1) IT7919717A0 (fr)
NO (1) NO790320L (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH441623A (de) * 1964-05-20 1967-08-15 Sandoz Ag Verfahren zur Herstellung neuer Antibiotica

Also Published As

Publication number Publication date
IT7919717A0 (it) 1979-01-30
DK40279A (da) 1979-08-02
NO790320L (no) 1979-08-02
JPS54112885A (en) 1979-09-04
FR2416231A1 (fr) 1979-08-31

Similar Documents

Publication Publication Date Title
FR2414814B1 (fr)
FR2414588B1 (fr)
FR2415341B1 (fr)
FR2414191B1 (fr)
FR2416940B1 (fr)
FR2414043B1 (fr)
FR2416428B1 (fr)
FR2415520B1 (fr)
AU3898778A (fr)
FR2415333B1 (fr)
AU3803078A (fr)
FR2414149B2 (fr)
FR2416231B1 (fr)
AU73950S (fr)
AU3892778A (fr)
BG25818A1 (fr)
BG25806A1 (fr)
BG25842A1 (fr)
BG25849A1 (fr)
BG25836A1 (fr)
BG25835A1 (fr)
BG25871A1 (fr)
BG25872A1 (fr)
BG25874A1 (fr)
BG25854A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse